Searchable abstracts of presentations at key conferences in endocrinology

ea0029p457 | Clinical case reports - Thyroid/Others | ICEECE2012

Malignant, ectopic ACTH secreting occult neuroendocrine tumor: a case report

Mannelli M. , Lotti F. , Pupilli C. , Biagini C. , Piccini V. , Forti G.

Introduction: Occult neuroendocrine tumors are still a difficult diagnostic/therapeutic challenge.Case report: In November 2007, a 29-years-old Caucasian woman was admitted to our in-patients clinic with a 2-month history of rapidly progressing signs and symptoms of chronic hypercortisolism, including a bipolar disorder in psychosis. On admission the patient presented with hypokalemia (3.2 mEq/l), high levels of plasma (3164 nmol/l) and urinary free (26 ...

ea0029p1758 | Thyroid cancer | ICEECE2012

BRAFV600E mutation is an indipendent predictive prognostic factor for persistent/recurrent disease in low risk differentiated thyroid cancer patients: a 5 year follow up study

Viola D , Torregrossa L , Giannini R , Ugolini C , Biagini A , Romei C , Molinaro E , Agate L , Basolo F , Pinchera A , Vitti P , Elisei R

BRAFV600E mutation is the most frequent genetic alteration (29–83%) of papillary thyroid carcinoma (PTC). Many authors have demonstrated that the presence of the mutation is associated with a more advanced tumor stage at diagnosis and a worse outcome but anyone assessed if BRAFV600E mutation could be useful prognostic marker in low risk PTC patients (T1-T2N0M0, 7th TNM classification).Aim of this study was to evaluate if the presence of BRAFV600E mu...